Article Information
History
- April 6, 2020.
Article Versions
- You are currently viewing Version 1 of this article (April 6, 2020 - 01:33).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Fan Wu*,
- Aojie Wang,
- Mei Liu,
- Qimin Wang,
- Jun Chen,
- Shuai Xia,
- Yun Ling,
- Yuling Zhang,
- Jingna Xun,
- Lu Lu,
- Shibo Jiang,
- Hongzhou Lu,
- Yumei Wen and
- Jinghe Huang*
- Shanghai Public Health Clinical Center and Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan University, Shanghai, China
- ↵*Correspondence to: Dr. Jinghe Huang, 86-21-37990333-7326, Email: Jinghehuang{at}fudan.edu.cn; or Dr. Fan Wu, 86-21-37990333-5295, Email: wufan{at}fudan.edu.cn;
Posted April 06, 2020.
Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications
